AGP Picks
View all

Biological safety testing market seen reaching $11.34 billion by 2030

Nov. 6, 2026
Biological safety testing market seen reaching $11.34 billion by 2030
By AI, Created 00:30 UTC, Nov 06, 2026, AGP -

The Business Research Company says the global market for biological safety testing products and services is growing as vaccine, biologics and gene therapy development expands. The market is projected to rise from $6.12 billion in 2025 to $11.34 billion by 2030, with North America leading in 2025 and Asia-Pacific expected to grow fastest.

Why it matters: - Biological safety testing helps verify that biologic medicines are free from bacteria, viruses, fungi and other contaminants before they reach patients. - Demand is rising alongside faster development of vaccines, gene therapies and other biologics, making testing a bigger part of drug development and release. - The market outlook points to sustained investment in safety tools, automated systems and outsourced testing capacity.

What happened: - The Business Research Company released a report on the global biological safety testing products and services market covering 2026-2035. - The report estimates the market at $6.12 billion in 2025 and $6.93 billion in 2026. - The report projects the market will reach $11.34 billion by 2030. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific is expected to be the fastest-growing region over the forecast period. - The full report and a free sample are available online.

The details: - The market's 2025-to-2026 growth rate is 13.3%, according to the report. - The report forecasts a 13.1% CAGR from 2026 to 2030. - Historical growth was driven by increased vaccine production, expanding pharmaceutical manufacturing, stricter regulatory oversight, broader use of cell and gene therapies and more clinical research activity. - Forecast growth is tied to demand for biologics safety assays, investment in automated testing systems, expansion of cell and gene therapy pipelines, faster release testing requirements and stronger contamination controls. - Emerging trends include rapid microbial detection, automated sterility testing, PCR-based safety testing and outsourced biological testing services. - The report also highlights a stronger emphasis on compliance with regulatory standards. - The market scope covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

Between the lines: - Gene therapy is becoming a key demand driver because safety testing is essential for viral vectors and genetic materials used in treatment development. - The market is shifting toward faster, more automated and more specialized testing as biologics pipelines become more complex. - Companies that can support quicker release testing and lower contamination risk may be better positioned as regulatory expectations tighten. - In January 2024, the American Society of Gene & Cell Therapy reported a 10% increase in gene therapies entering Phase III clinical trials in the fourth quarter of 2023, the first quarterly increase since the third quarter of 2022.

What's next: - The report expects continued growth through 2030 as biologics and gene therapy pipelines expand. - Demand should increase for advanced safety assays, automated platforms and outsourced testing services. - The Business Research Company says its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrices, Excel forecasting dashboards, market hotspot infographics, key technology analysis and updated graphics and tables. - More information is available through the company’s LinkedIn page and social media.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Africa News Guide

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Africa News Guide

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.